Cargando…
Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917
Enteric microbial pathogens, including Escherichia coli, Shigella and Cryptosporidium species, take a particularly heavy toll in low-income countries and are highly associated with infant mortality. We describe here a means to display anti-infective agents on the surface of a probiotic bacterium. Be...
Autores principales: | Gelfat, Ilia, Aqeel, Yousuf, Tremblay, Jacqueline M., Jaskiewicz, Justyna J., Shrestha, Anishma, Lee, James N., Hu, Shenglan, Qian, Xi, Magoun, Loranne, Sheoran, Abhineet, Bedenice, Daniela, Giem, Colter, Manjula-Basavanna, Avinash, Pulsifer, Amanda R., Tu, Hann X., Li, Xiaoli, Minus, Marilyn L., Osburne, Marcia S., Tzipori, Saul, Shoemaker, Charles B., Leong, John M., Joshi, Neel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477280/ https://www.ncbi.nlm.nih.gov/pubmed/36107831 http://dx.doi.org/10.1371/journal.ppat.1010713 |
Ejemplares similares
-
Plasmid Vectors for in Vivo Selection-Free
Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020) -
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019) -
A highly antigenic fragment within the zoonotic Cryptosporidium parvum Gp900 glycoprotein (Domain 3) is absent in human restricted Cryptosporidium species
por: Dayao, Denise Ann E., et al.
Publicado: (2023) -
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019) -
Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)